Workflow
ANTENGENE(06996)
icon
Search documents
德琪医药(06996) - 翌日披露报表
2025-09-16 11:38
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 確認 不適用 第一章節註釋: 若股份曾以超過一個每股價格發行/出售/購回/贖回,則須提供每股成交量加權平均價格。 若購回/贖回股份將於期終結存日期之後購回/贖回結算完成之時予以註銷,則該等購回/贖回股份仍屬A部所述期終結存當日的已發行股份的一部分。該等購回/贖回股份的詳情應在B部作 出披露。 表格類別: 股票 狀態: 新提交 公司名稱: 德琪醫藥有限公司 呈交日期: 2025年9月16日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證 ...
智通港股回购统计|9月12日
Zhi Tong Cai Jing· 2025-09-12 01:21
Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on September 11, 2025, with Tencent Holdings leading in both the number of shares repurchased and the total amount spent [1][2]. Company Buyback Details - Tencent Holdings (00700) repurchased 874,000 shares for a total of 550 million, with a year-to-date total of 54.758 million shares, representing 0.596% of its total share capital [2]. - Hang Seng Bank (00011) repurchased 210,000 shares for 24.882 million, with a year-to-date total of 6.12 million shares, representing 0.325% of its total share capital [2]. - Stone Four Pharmaceutical Group (02005) repurchased 6 million shares for 18.1433 million, with a year-to-date total of 22.6 million shares, representing 0.766% of its total share capital [2]. - MGM China (02282) repurchased 1 million shares for 16.2463 million, with a year-to-date total of 18.6274 million shares, representing 0.490% of its total share capital [2]. - Other notable companies include: - China Hongqiao (01378) with 100,500 shares repurchased for 2.4636 million, totaling 149 million shares, representing 1.590% of its total share capital [2]. - Weigao Group (01066) with 429,200 shares repurchased for 2.4248 million, totaling 10.4532 million shares, representing 2.315% of its total share capital [2]. - Coolpad Group (02369) with 924,000 shares repurchased for 1.2036 million, totaling 1.2519 million shares, representing 3.057% of its total share capital [2].
德琪医药(06996.HK)9月11日耗资19.95万港元回购2.7万股
Ge Long Hui· 2025-09-11 10:41
格隆汇9月11日丨德琪医药(06996.HK)公告,9月11日耗资19.95万港元回购2.7万股。 ...
德琪医药-B(06996)9月11日斥资19.95万港元回购2.7万股
Zhi Tong Cai Jing· 2025-09-11 10:29
智通财经APP讯,德琪医药-B(06996)发布公告,于2025年9月11日,该公司斥资19.95万港元回购2.7万 股。 ...
德琪医药(06996) - 翌日披露报表
2025-09-11 10:21
如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 德琪醫藥有限公司 呈交日期: 2025年9月11日 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06996 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | | 佔有關事件 ...
智通港股回购统计|9月11日
智通财经网· 2025-09-11 01:15
Summary of Key Points Core Viewpoint - Multiple companies, including Tencent Holdings and Hang Seng Bank, conducted share buybacks on September 10, 2025, with Tencent leading in both the number of shares repurchased and the total amount spent [1]. Company-Specific Summaries - **Tencent Holdings (00700)**: - Repurchased 866,000 shares for a total of 550 million [2]. - Year-to-date total repurchased shares reached 53.884 million, accounting for 0.586% of total shares [2]. - **Hang Seng Bank (00011)**: - Repurchased 210,000 shares for a total of 24.8171 million [2]. - Year-to-date total repurchased shares reached 5.91 million, accounting for 0.314% of total shares [2]. - **China Hongqiao (01378)**: - Repurchased 980,000 shares for a total of 23.7363 million [2]. - Year-to-date total repurchased shares reached 149 million, accounting for 1.590% of total shares [2]. - **MGM China (02282)**: - Repurchased 1 million shares for a total of 16.0869 million [2]. - Year-to-date total repurchased shares reached 17.6274 million, accounting for 0.464% of total shares [2]. - **COSCO Shipping (02039)**: - Repurchased 742,900 shares for a total of 5.9284 million [2]. - Year-to-date total repurchased shares reached 11.2407 million, accounting for 0.360% of total shares [2]. - **Coolpad Group (02369)**: - Repurchased 1,036,000 shares for a total of 1.3156 million [2]. - Year-to-date total repurchased shares reached 11.595 million, accounting for 2.831% of total shares [2]. - **Other Notable Companies**: - Various companies such as Weigao Group, Mengniu Dairy, and others also participated in share buybacks, with amounts and shares varying significantly [2].
德琪医药(06996.HK)9月10日耗资112.1万港元回购14.6万股
Ge Long Hui· 2025-09-10 11:15
Summary of Key Points - The company, 德琪医药 (Dechra Pharmaceuticals), announced a share buyback on September 10, 2023, spending HKD 1.121 million to repurchase 146,000 shares [1]
德琪医药(06996.HK)9月10日耗资112.12万元回购A股股份14.6万股
Ge Long Hui· 2025-09-10 10:59
Group 1 - The company, Deqi Pharmaceutical (06996.HK), announced a share buyback on September 10, 2023, spending 1.1212 million yuan to repurchase 146,000 A-shares at a price range of 7.61 to 7.69 yuan per share [1]
德琪医药-B9月10日斥资112.13万港元回购14.6万股
Zhi Tong Cai Jing· 2025-09-10 10:54
Group 1 - The company, 德琪医药-B (06996), announced a share buyback plan on September 10, 2025, with an expenditure of HKD 1.1213 million [1] - A total of 146,000 shares will be repurchased at a price range of HKD 7.61 to HKD 7.69 per share [1]
德琪医药(06996) - 翌日披露报表
2025-09-10 10:47
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 德琪醫藥有限公司 呈交日期: 2025年9月10日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06996 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份(不包括庫存股份)數 目 | | 佔有關事件 ...